JAN Stock Forecast & Price Target

Janus Living is a publicly traded REIT that specializes in the senior housing sector and all of its properties are operated under RIDEA structures. The company recently completed an IPO and received $950 million in proceeds, and with additional investments expected to close by 3Q26, the company will have $900 million to deploy, with a projected 6% going-in cap rate that is expected to increase to 7.5%. The recent secondary offering of $700 million at a 25% premium to the IPO price, combined with the company's strong financial position, makes redeployment immediately accretive and supports the potential for organic growth. Additionally, the company's external management structure may be disliked by some investors, but it is currently in the interest of the large equity owner, Healthpeak. Overall, we have a positive outlook on Janus Living's stock as we expect it to continue utilizing its strong financial position to deploy capital and generate solid organic growth.

Janus Living is facing numerous risks that could negatively impact its financial performance in the future. The company's current valuation is expensive, trading at a 43% premium to our NAV estimate. The supply of senior housing may increase, leading to a shift away from the positive narrative for Janus. Additionally, a potential slowdown in the US economy could make senior housing less affordable for residents. Furthermore, questions around the investment market specific to CCRCs could pose a risk to Janus. The recent equity issuance of $600 million and availability of $2.25 billion in liquidity allow Janus to capitalize on its growing pipeline of investments. However, its investment pipeline includes deals with a high cost of $421K per unit, and the initial yields are projected to be in the 6% range, stabilizing at 7-8% in the next two to three years. Janus is externally managed by Healthpeak Properties, which has made significant progress towards achieving its Corporate Impact Plan goals, but these goals may not directly impact Janus' financial performance. Overall, these factors contribute to our negative outlook on Janus Living's stock.